Appraisal of evidence reliability and applicability of Paxlovid as treatment for SARS‐COV‐2 infection: A systematic review
C Zhu, JY Yin, X Chen, M Liu… - Reviews in Medical …, 2023 - Wiley Online Library
This study aimed to clarify the beneficial effect and the clinical application value of Paxlovid
in the treatment of coronavirus disease‐19 (COVID‐19) through a systematic review …
in the treatment of coronavirus disease‐19 (COVID‐19) through a systematic review …
Shared pathogenicity features and sequences between EBV, SARS-coV-2, and HLA class I molecule-binding motifs with a potential role in autoimmunity
Y Adiguzel, N Mahroum, S Muller, M Blank… - Clinical Reviews in …, 2023 - Springer
Epstein-Barr virus (EBV) and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2) are extraordinary in their ability to activate autoimmunity as well as to induce diverse …
2) are extraordinary in their ability to activate autoimmunity as well as to induce diverse …
[PDF][PDF] COVID-19: Epidemiology, virology, and prevention
K McIntosh, MS Hirsch, A Bloom - UpToDate. Available online …, 2021 - hoiyhoctphcm.org.vn
Coronaviruses are important human and animal pathogens. At the end of 2019, a novel
coronavirus was identified as the cause of a cluster of pneumonia cases in Wuhan, a city in …
coronavirus was identified as the cause of a cluster of pneumonia cases in Wuhan, a city in …
The case fatality rate of COVID‐19 during the Delta and the Omicron epidemic phase: A meta‐analysis
As coronavirus variants are constantly occurring, we tried to understand more about the
omicron and delta variants that have hit the world. We provided dynamic information on the …
omicron and delta variants that have hit the world. We provided dynamic information on the …
[HTML][HTML] A phase 2/3 study of S-217622 in participants with SARS-CoV-2 infection (Phase 3 part)
H Yotsuyanagi, N Ohmagari, Y Doi, T Imamura… - Medicine, 2023 - journals.lww.com
Background: Limited treatment options exist for patients with mild-to-moderate coronavirus
disease 2019 (COVID-19), irrespective of vaccination history or risk status. Ensitrelvir is a …
disease 2019 (COVID-19), irrespective of vaccination history or risk status. Ensitrelvir is a …
Racial and Ethnic Disparities in Age-Specific All-Cause Mortality During the COVID-19 Pandemic
Importance The end of the COVID-19 public health emergency (PHE) provides an
opportunity to fully describe pandemic-associated racial and ethnic mortality disparities. Age …
opportunity to fully describe pandemic-associated racial and ethnic mortality disparities. Age …
[HTML][HTML] Uncoupling of all-cause excess mortality from COVID-19 cases in a highly vaccinated state
Uncoupling of all-cause excess mortality from COVID-19 cases in a highly vaccinated state -
The Lancet Infectious Diseases Skip to Main Content Advertisement The Lancet Infectious …
The Lancet Infectious Diseases Skip to Main Content Advertisement The Lancet Infectious …
Coinfection and superinfection in ICU critically ill patients with severe COVID-19 pneumonia and influenza pneumonia: are the pictures different?
Z Chen, Q Zhan, L Huang, C Wang - Frontiers in Public Health, 2023 - frontiersin.org
Background Similar to influenza, coinfections and superinfections are common and might
result in poor prognosis. Our study aimed to compare the characteristics and risks of …
result in poor prognosis. Our study aimed to compare the characteristics and risks of …
[HTML][HTML] Identifying age-and sex-specific COVID-19 mortality trends over time in six countries
Objectives The COVID-19 pandemic is characterized by successive waves that each
developed differently over time and through space. We aim to provide an in-depth analysis …
developed differently over time and through space. We aim to provide an in-depth analysis …
MIS-C across three SARS-CoV-2 variants: changes in COVID-19 testing and clinical characteristics in a cohort of US children
J Laird-Gion, A Dionne, K Gauvreau, A Baker… - European Journal of …, 2023 - Springer
As new variants of SARS-Co-V 2 have emerged over time and Omicron sub-variants have
become dominant, the severity of illness from COVID-19 has declined despite greater …
become dominant, the severity of illness from COVID-19 has declined despite greater …